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Abstract
Celiac disease is caused by an uncontrolled immune response to gluten, a heterogeneous mixture of wheat storage
proteins, including the a-gliadins. It has been shown that a-gliadins harbor several major epitopes involved in the disease
pathogenesis. A major step towards elimination of gluten toxicity for celiac disease patients would thus be the elimination
of such epitopes from a-gliadins. We have analyzed over 3,000 expressed a-gliadin sequences from 11 bread wheat cultivars
to determine whether they encode for peptides potentially involved in celiac disease. All identified epitope variants were
synthesized as peptides and tested for binding to the disease-associated HLA-DQ2 and HLA-DQ8 molecules and for
recognition by patient-derived a-gliadin specific T cell clones. Several specific naturally occurring amino acid substitutions
were identified for each of the a-gliadin derived peptides involved in celiac disease that eliminate the antigenic properties
of the epitope variants. Finally, we provide proof of principle at the peptide level that through the systematic introduction
of such naturally occurring variations a-gliadins genes can be generated that no longer encode antigenic peptides. This
forms a crucial step in the development of strategies to modify gluten genes in wheat so that it becomes safe for celiac
disease patients. It also provides the information to design and introduce safe gluten genes in other cereals, which would
exhibit improved quality while remaining safe for consumption by celiac disease patients.
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Introduction
Celiac Disease (CD) is an intestinal T cell-mediated disease
caused by the gluten fraction of wheat or the homologous proteins
from barley or rye. CD has prevalence between 0.5 and 2% in
human populations [1] and is characterized by a chronic intestinal
inflammation upon ingestion of gluten proteins. Recently, the
molecular aspects have been comprehensively addressed in several
review papers [2–5]. In short, in CD patients CD4+ T cells are
present in the lamina propria that secrete interferon-gamma upon
recognition of gluten-derived peptides bound to HLA-DQ2 or
HLA-DQ8 molecules present on antigen presenting cells.
Strikingly, most of the gluten peptides implicated in CD require
modification by the enzyme tissue transglutaminase before they
can bind to the disease-predisposing HLA-DQ molecules and
trigger T cell responses [2–5]. In addition to the adaptive CD4+ T
cell response to gluten, CD is characterized by the upregulation of
IL-15, an intraepithelial T cell infiltrate expressing the NKG2D
receptor, and the overexpression of a ligand for NKG2D (MICA)
[6,7].
Many gluten peptides with T cell stimulatory properties have
now been identified. Such peptides have been found in wheat a-,
c-, and v-gliadins as well as in low molecular weight (LMW) and
high molecular weight (HMW) glutenins [8–14]. Several studies
have demonstrated that peptides derived from a-gliadins induce
strong T cell responses in the large majority of patients, while
responses to the other peptides are less frequently found [8–10,13].
An a-gliadin derived 33-mer peptide (amino acid sequence
LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF) was identi-
fied that encodes six partially overlapping T cell epitopes and has
very potent T cell stimulatory properties [13]. It harbours the
p56–75 peptide (LQLQPFPQPQLPYPQPQLPY) that has been
identified as the dominant gluten epitope [9,10]. Furthermore, a-
gliadins are the only gluten molecules that harbor the p31-43/49
peptide that has been implicated in the innate immune response
induced by gluten [7].
The a-gliadins are a gene family encoded by the Gli-2 loci, Gli-
A2, Gli-B2 and Gli-D2, located on the short arm of three
homoeologous chromosomes (6AS, 6BS and 6DS) of hexaploid
bread wheat (Triticum aestivum L.). These loci may contain from 25–
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35 to even 150 a-gliadin genes per haploid genome [15–17],
although most of these (72–95%) are presumably pseudogenes
[16,17]. Sequencing of genomic a-gliadin clones from hexaploid
bread wheat enabled to differentiate the sequences according to
their loci Gli-A2, Gli-B2 and Gli-D2 based on genome-specific
SNPs [16,17]. Relevant for CD, the occurrence and frequency of
the HLA-DQ2 epitopes DQ2-Glia-a1, DQ2-Glia-a2 and DQ2-
Glia-a3 (previously designated Glia-a20, ref. 12] and the HLA-
DQ8 T-cell epitope DQ8-Glia-a1 also differs between the loci
[17]. This was corroborated by the observation that T cell clones
specific for the DQ2-Glia-a2 epitope did not recognise gluten
derived from diploid species carrying the S-genome, ancestrally
related to the B genome of bread wheat, while gluten derived from
diploid A- and D-genome species was recognized [18]. Variation
in T cell stimulatory capacity of cereal-derived gluten was
observed with other T cell clones as well [19–21]. Indeed,
differences have been observed in the T cell stimulatory capacity
of pasta and bread wheat varieties [22,23], but none were safe for
CD patients.
Given the overall importance of the a-gliadins in CD we set out
to determine the naturally existing sequence variation in CD
epitopes as deduced from a-gliadin transcripts from developing
wheat grains. The immunogenic potential of these epitope variants
was subsequently tested in T-cell proliferation assays. This
produced insight in which key amino acid changes are sufficient
to abolish T-cell recognition. Finally, we verified that the observed
differences in antigenicity of a-gliadin peptides derived from
diploid species corresponded to differences in the antigenicity of
the gluten from these species, ancestrally related to bread wheat.
Altogether the results offer a molecular basis for differential CD
toxicity of the wheat genomes. Based upon these results we present
a rational strategy to develop genes that encode a-gliadins that are
safe for consumption by celiac disease patients.
Results
Genetic variation in a-gliadin (Gli-2) transcripts
In total 3022 expressed a-gliadin sequences (expressed sequence
tags and mRNA sequences from NCBI and Unigene) originating
from 11 different T. aestivum L. varieties were analyzed. These a-
gliadin transcripts were grouped into 55 contigs with at least 90%
sequence homology. Forty per cent of the a-gliadin transcripts
clustered with A genomic sequences and were attributed to locus
Gli-A2, 35% originated from Gli-D2 and only 25% came from Gli-
B2 (Fig. S1). After tracing all non-synonymous DNA polymor-
phisms 83 different transcript contigs were obtained for the 39
region of the gene that each contained at least four sequence
equivalents. This indicates a high sequence diversity among
expressed a-gliadin sequences in these 11 T. aestivum L. varieties.
Variants of T cell stimulatory and innate stimulatory
sequences
The N-terminal region of a-gliadins contains the p31-43 epitope
implicated in the innate immune response, and the immunodo-
minant DQ2-Glia-a1 and DQ2-Glia-a2 epitopes as well as the
DQ2-Glia-a3 T cell epitope. The carboxyl-terminal part encodes
the immunodominant DQ8-Glia-a1 T cell epitope (Table 1). To
obtain information on the immunogenic potential of the various a-
gliadins, the translated amino acid sequences for each locus were
checked for the presence of canonical T cell epitopes and variants
thereof. Tables 2, 3, 4, 5 present the most frequently expressed
epitope variants (.5 transcripts each).
We observed that canonical DQ2-Glia-a1 (Table 2) and DQ2-
Glia-a3 epitopes (Table 4) were only present in Gli-A2 and Gli-D2
transcripts and that the canonical DQ2-Glia-a2 motif (Table 3)
was unique for Gli-D2 transcripts (72% of all Gli-D2 transcripts
contained at least one DQ2-Glia-a2 epitope core). DQ8-Glia-a1
canonical epitopes were present in Gli-D2 and Gli-B2 transcripts
only (Table 5). The canonical p31-43 motif was not restricted to
transcripts from a specific locus and was found in transcripts from
all a-gliadin loci.
In addition to the canonical epitope motifs, a large series of
sequence variants with one or two amino acid substitutions were
detected (Tables 2, 3, 4, 5). The large majority of the Gli-B2
gliadins contained sequence variants of the DQ2-Glia-a1, DQ2-
Glia-a2, and DQ2-Glia-a3 epitopes with two amino acid
substitutions. Furthermore, Gli-A2 transcripts harbored a proline
to serine substitution at position 8 (p8) of the DQ2-Glia-a2 epitope
and a sequence variant (QGSFRP(S/F)QQN, amino acid
substitution in bold) of the DQ8-Glia-a1 epitopes. Importantly,
the 33-mer peptide (LQLQPFPQPQLPYPQPQLPYPQPQL-
PYPQPQPF) that is highly resistant to degradation in the
gastrointestinal tract and contains six overlapping DQ2-Glia-a1
and DQ2-Glia-a2 epitopes, conferring superior T cell stimulatory
properties [13], was only observed in a subset of the a-gliadins
from the Gli-D2 locus and never in the a-gliadins from the Gli-A2
Table 1. Amino acid sequences of a-gliadin derived peptides.
Immune
response
Restriction
element Core-Sequence
DQ2-Glia-a1 Adaptive HLA-DQ2 P{F/Y}PQPQLPY
DQ2-Glia-a2 Adaptive HLA-DQ2 PQPQLPYPQ
DQ2-Glia- a3 Adaptive HLA-DQ2 FRPQQPYPQ
DQ8-Glia-a1 Adaptive HLA-DQ8 QGSFQPSQQ
P31-43 Innate not applicable PGQQQPFPPQQPY
Five antigenic peptides derived from a-gliadins are known to be involved in
celiac decease. For the peptides that can provoke an adaptive immune
response in CD patients (HLA-DQ2 restricted or HLA-DQ8 restricted) the
minimal 9-mer ‘‘canonical’’ epitope cores are shown. One peptide, p31-43, is
known to be involved in an innate immune response observed in CD. For each
of the epitopes is specified the name, which immune response it evokes, the
restriction element and the amino acid sequence.
doi:10.1371/journal.pone.0015637.t001
Table 2. HLA-DQ2-Glia-a1 epitope variants expressed in
bread wheat.
Gli-A2 Gli-B2 Gli-D2 N
PFPQPQLPY 466 520 986
PYPQPQLPY 93 93
PFLQPQLPY 106 106
PFSQPQLPY 94 94
PFPQPQLSY 7 54 61
PFPHPQLPY 29 29
PFPQAQLPY 6 6
Total 673 702 1375
Expressed variants of the DQ2-Glia-a1 epitope represented by $5 transcripts
and the number of transcripts per epitope variants per chromosomal locus (Gli-
A2, Gli-B2 or Gli-D2). N = total transcript count per variant. In bold: amino acid
variation.
doi:10.1371/journal.pone.0015637.t002
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and Gli-B2 loci. The latter expressed substantially truncated
versions of the 33-mer (Fig. S2).
T cell stimulatory capacity of a-gliadin derived peptides
Several of the amino acid variants that we found in the a-gliadin
transcriptome have never been described before while some have
been described but were never tested for their T cell stimulatory
capacity. In order to determine which variants are capable of
inducing T cell responses, the DQ2-Glia-a1, DQ2-Glia-a2, DQ2-
Glia-a3, and DQ8-Glia-a1 variants were synthesized as 15- or 16-
mer peptides and tested for their capacity to bind to HLA-DQ2
and induce in vitro proliferation of HLA DQ2- or DQ8-restricted T
cell clones.
DQ2-Glia-a1 variants. Virtually all peptides that carry the
canonical 9-mer Glia-a1 epitope core P1{F/Y}2P3Q4P5E6L7P8Y9
(in which the glutamic acid at p6 is introduced by TG2-deamidation
of the original glutamine) were able to stimulate DQ2-Glia-a1 T
cells. Only an arginine residue at the position preceding the epitope
core diminished T cell stimulation. In the core sequence, several
amino acid substitutions diminished or abolished the T cell
stimulatory capacity, such as a proline to serine substitution at p3
or p8 and a proline to alanine substitution at p5 (Table 6, no. 3).
Peptides in which an amino acid was deleted at p3 or p4 were not
causing any proliferation of the T cells. Strikingly, such safe peptides
are all from locus Gli-B2 (Table 6, Fig. S3).
DQ2-Glia-a2 variants. Full responses of DQ2-Glia-a2 T
cells were only observed against peptides that carry the core P/
F1Q2P3E4L5P6Y7P8Q9. A deletion of the glutamine at p2,
indicative for a-gliadins from locus Gli-B2, or substitution of this
glutamine by histidine diminished or abolished the stimulatory
capacity. Furthermore, a single substitution of the proline for an
serine residue at either p6 or p8 abolished the T cell stimulating
capacity. The latter substitution is found in a-gliadins from locus
Gli-A2 (Table 6).
DQ2-Glia-a3 variants. Also for this epitope several amino
acid substitutions were found to destroy T cell stimulatory
capacity, including an arginine to proline substitution at p2,
which is found in a-gliadins from Gli-B2 (Table 6).
DQ8-Glia-a1 variants. While several amino acid substi-
tutions were found to influence T cell recognition of the canonical
sequence Q1G2S3F4Q5P6S7Q8Q9, a single serine to phenylalanine
substitution at p3 and a single glutamine to arginine substitution at
p5 were found to completely destroy T cell stimulatory properties
(Table 6). While the former T cell stimulatory variants are found
in a-gliadins from Gli-D2 and Gli-B2, the glutamine to arginine
variants are from Gli-A2 (Table 5, Fig. S2).
Thus, the a-gliadins encoded by Gli-A2 of bread wheat are
marked with a specific single amino acid substitution (P to S at p8)
Table 3. DQ2-Glia-a2 epitope variants expressed in bread
wheat.
Gli-A2 Gli-B2 Gli-D2 N
PQPQLPYPQ 607 607
PQPQLPYSQ 431 431
FPPQLPYPQ 382 382
LQPQLPYSQ 106 106
FLPQLPYPQ 31 31
SQPQLPYSQ 85 85
PQPQLSYPQ 54 54
PQPHLPYPQ 30 30
PHPQLPYPQ 29 29
PQPQLSYSQ 7 7
PQAQLPYSQ 6 6
PQPQPQYPQ 6 6
Total 629 419 726 1774
Expressed variants of the DQ2-Glia-a2 epitope represented by $5 transcripts
and the number of transcripts per epitope variants per chromosomal locus (Gli-
A2, Gli-B2 or Gli-D2). N = total transcript count per variant. In bold: amino acid
variation.
doi:10.1371/journal.pone.0015637.t003
Table 4. DQ2-Glia-a3 epitope variants expressed in bread
wheat.
Gli-A2 Gli-B2 Gli-D2 N
FRPQQPYPQ 650 449 1099
FPPQQPYPQ 732 687 606 2025
FPSQQPYPQ 179 8 187
FRPQQSYPQ 157 157
FPPQQPYPH 148 148
FPAQQPYPQ 56 56
FPPQQSYPQ 18 18
FPGQQPYPQ 20 20
FQPQQPYPQ 13 13
FLPQQPYPQ 8 8
FRPQQQYPQ 6 6
Total 1395 1108 1234 3737
Expressed variants of the DQ2-Glia-a3 epitope represented by $5 transcripts
and the number of transcripts per epitope variants per chromosomal locus (Gli-
A2, Gli-B2 or Gli-D2). In italics: DQ2-Glia-a3 variants located on the position of
the innate responsive element, p31-43. N = total transcript count per variant. In
bold: amino acid variation.
doi:10.1371/journal.pone.0015637.t004
Table 5. DQ8-Glia-a1 epitope variants expressed in bread
wheat.
Gli-A2 Gli-B2 Gli-D2 N
QGSFQPSQQN 186 381 567
QGSFRPSQQN 409 409
QGFFQPSQQN 114 114
QGSFRPFQQN 103 103
QVSFQPSQLN 112 112
QGSFQSSQQN 111 111
QGSFQPFQQN 4 27 31
QGFFQPFQQN 6 6
Total 512 413 528 1453
Expressed variants of the DQ8-Glia-a1 epitope, represented by $5 transcripts
and the number of transcripts per epitope variants per chromosomal locus (Gli-
A2, Gli-B2 or Gli-D2). N = total transcript count per variant. In bold: amino acid
variation.
doi:10.1371/journal.pone.0015637.t005
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and lack the capacity to stimulate Glia-a2 T cell clones, whereas a-
gliadins encoded by Gli-B2 carry a deletion that prevents Glia-a1
T cell clone stimulation. Alpha-gliadins with the two intact
epitopes, Glia-a1 and Glia-a2, are encoded by Gli-D2 (Tables 2
and 3).
T cell stimulatory capacity of diploid wheat accessions
Previously, differential reactivity of a-gliadin specific T cell
clones against gluten extracts from diploid wheat accessions has
been reported [18,19]. In order to link such differential reactivity
to the presence of specific epitope variants, a panel of diploid
wheat accessions containing either the A, S or D genome was
tested for their reactivity of an a-gliadin specific monoclonal
antibody (mAb) and T cells.
Pepsin-trypsin digests of gluten extracts from kernels of 29
diploid Triticum and Aegilops accessions were prepared and tested in
a competition ELISA with a mAb specific for a sequence partially
overlapping with the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes
(Fig. 1A) and, after treatment with TG2, with T cell clones
specific for either the DQ2-Glia-a1 and DQ2-Glia-a2 epitope
(Fig. 1B and 1C). The results indicate that the mAb reacts
strongly with all extracts except three derived from diploids
expressing the S genome (Fig. 1A). Similarly, and in agreement
with previous results [18], extracts from A, S and D origin were
capable of stimulating the DQ2-Glia-a1 specific T cell clone
(Fig. 1B) while the extracts of the diploids expressing the A
genome failed to stimulate the DQ2-Glia-a2 specific T cell clone
(Fig. 1C).
Based on our observation that the a-gliadins expressed from
locus Gli-A2 of the T. aestivum A genome carry a variant DQ2-
Glia-a2 epitope in which the proline at p8 has been replaced by a
serine, and our experimental result that introducing this
substitution in a peptide leads to loss of DQ2-Glia-a2 T cell
stimulatory properties (Table 6), we wanted to determine if this
amino acid substitution was indeed the cause of loss of
immunogenicity. For this purpose we sequenced the a-gliadin
locus of three diploid wheat (T. monococcum, A genome) accessions.
In agreement with the results from hexaploid wheat transcripts
(Fig. S2) we observed that the a-gliadin transcripts from T.
Table 6. T cell proliferation and HLA-DQ2 binding capacity of DQ2-Glia-a variants.
No. Peptide locus
IC50
DQ2-Glia-a1
Glia-a1
T cell clone
IC50
DQ2-Glia-a2
Glia-a2
T cell clone
1 QLQPFPQPELPYPQPE Gli-D2 5 + 18 +
2 QLQPFPQPELPYPQPQ Gli-D2 5 + 34 +
3 QLQPFPQAELPYSQPQ Gli-D2 8 6 11 -
4 QLQPFPQPELSYPQPQ Gli-D2 12 - 24 -
5 QLQRPFPQPELPYPQPE Gli-D2 14 6 19 +
6 QLQPFPQPELPYTH Gli-D2 21 + 21 -
7 QLQPFPHPELPYPQPQ Gli-D2 42 + 41 6
8 QLQPFSQPELPYSQPQ Gli-A2 7 6 32 -
9 QLQPFPQPELPYSQPQ Gli-A2 57 + 41 -
10 QLQPFPQPELPYSQPE Gli-A2 67 + 24 -
11 QPQPFL-PELPYPQPE Gli-B2 4 - 4 6
12 QPQPF-QPELPYPQPE Gli-B2 8 - 8 +
13 QPQEFP-PELPYPQPE Gli-B2 45 - 45 -
14 QPQQFP-PELPYPQPE Gli-B2 86 - 86 -
15 QPQPFP-PELPYPQTQP Gli-B2 nd - nd -
IC50
DQ2-Glia-a3
Glia-a3
T cell clone
16 QPFRPEQPYPQPQPQ Gli-A2/D2 35 +
17 QPFPPEQPYPQPQPQ Gli-A2/D2/B2 3080 -
IC50
DQ8-Glia-a1
DQ8-Glia-a1
T cell clone
18 LGEGSFQPSQENP Gli-D2/B2 16 +
19 LGEGSFRPSQENP Gli-A2 33 -
20 LGEGFFQPSQENP Gli-D2 nd -
Variants of the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes as encoded by the a-gliadin transcriptome were synthesized as deamidated 14- to 17-mer peptides (column 1,
underlined: DQ2-Glia-a1/a2 epitope region) and tested for stimulation of DQ2-Glia-a1 and DQ2-Glia-a2 specific T cell clones in a proliferation assay. 6= 100 times
reduced T cell stimulation compared to the ‘canonical’ epitope; - = 1000 times reduced T cell stimulation compared to the ‘canonical’ epitope. For each epitope shorter
versions of the peptide variant, including the putative epitope core flanked by at least two amino acids, were tested in a cell free in vitro peptide binding assay for
binding to HLA-DQ2 antigen presenting cells (lysates from HLA-DR3/DQ2 positive EBV-transfored B-cells). IC50 DQ2-Glia-a1/a2=mean value of the half maximal
inhibitory concentration (IC50) returned by the binding assays for respectively DQ2-Glia-a1 and DQ2-Glia-a2 epitope variants. IC50 values were calculated based on the
observed competition between the tested peptides and biotin-labelled indicator peptides and indicate the concentration of the tested peptide required for half
maximal inhibition of the binding of the indicator peptide.
doi:10.1371/journal.pone.0015637.t006
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monococcum contain only a single form of DQ2-Glia-a1 and DQ2-
Glia-a2. Moreover, in the DQ2-Glia-a2 epitope the proline at p8
was consistently replaced by a serine (Table S1). Together these
results establish that this naturally occurring single amino acid
substitution is sufficient to completely eliminate the T cell
stimulatory properties of the DQ2-Glia-a2 epitope in gluten.
Differential reactivity of the DQ2-Glia-a3 specific T cells
towards the extracts of the diploids correlated with an arginine to
proline replacement at p2 in a-gliadins derived from the S-
genome, FRPQQPYPQR FPPQQPYPQ (Table 6).
Elimination of a-gliadin toxicity by a naturally occurring
single amino acid substitution
The large majority of known antigenic peptides derived from
wheat gluten, as well as homologous peptides derived from the
hordeins from barley and the secalins from rye, contain a proline
at p8 [24]. Based on our observation that a single proline to serine
substitution at p8 induced unresponsiveness of DQ2-Glia-a2
specific T cells and the previous observation that a similar
substitution at p8 of the DQ2-Glia-a1 epitope induced T cell
unresponsiveness (Table 6; peptide no. 4), we investigated if a
similar substitution would also eliminate the antigenic properties of
the DQ2-Glia-a3 epitope. Wild type versions of the DQ2-Glia-a1,
-a2 and -a3 epitopes as well as versions in which the proline at p8
was substituted by a serine were synthesized and tested in T cell
proliferation studies. As expected neither the substituted DQ2-
Glia-a1 epitope (QLQPFPQPELSYPQPQ) nor the substituted
DQ2-Glia-a2 epitope (QLQPFPQPELPYSQPQ) induced T cell
proliferation of respectively DQ2-Glia-a1 and DQ2-Glia-a2
specific T cells (Table 6). Likewise, the substituted DQ2-Glia-
a3 epitope failed to induce T cell activation (Fig. 2A).
We also analysed the effects of proline to serine substitutions in
the 33-mer a-gliadin derived peptide that encodes 6 partially
overlapping antigenic DQ2-Glia-a1 and -a2 sequences (Fig. 2B)
as well as in an elongated version of the 33-mer which also encodes
the DQ2-Glia-a3 epitope (Table S2). In all cases, the proline to
serine substitutions completely abrogated the response of DQ2-
Glia-a1, DQ2-Glia-a2 and DQ2-Glia-a3 specific T cell clones
(Fig. 2B, Table S2).
Finally, we tested the effect of systematic introduction of single,
double, triple and quadruple P to S substitutions in the DQ2-Glia-
a-1 peptide with five T cell clones isolated from small intestinal
biopsies of 3 CD patients. T cell responses of single T cell clones
were only observed for two of the single P to S substitutions at p3
and p5. In contrast, with a single P to S substitution at p8 and in
all but one of the other cases the substitutions completely
eliminated the T cell response of all five T cell clones (Fig. 3)
Thus, the naturally occurring proline to serine substitution
constitutes a universal approach to remove the antigenic
properties of HLA-DQ2 restricted a-gliadin peptides.
Figure 1. Presence of DQ2-Glia-a1 and DQ2-Glia-a2 epitopes in diploid wheat. Pepsin-trypsin digests of 29 diploid wheat accessions were
prepared and tested in a competition ELISA with a mAb specific for a sequence partially overlapping with the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes
and after deamidation with T cell clones specific for the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes. A: results of the competiton ELISA. B: T cell
proliferation assay with a DQ2-Glia-a1 specific T cell clone. C: T cell proliferation assay with a DQ2-Glia-a2 specific T cell clone. IL-2: proliferation of the
T cell clone under the influence of interleukin-2. Background: proliferation of the T cells in the presence of antigen presenting cells but no antigen.
Positive control: proliferation of the T cell clone in the presence of a synthetic peptide encoding the specific a-gliadin epitope and antigen presenting
cells. cpm: counts per minute. AA: diploid accessions with an A genome; SS: diploid accessions with an S genome; DD: diploid accessions with a D
genome.
doi:10.1371/journal.pone.0015637.g001
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Discussion
Although T cell responses to peptides derived from a-, c- and v-
gliadins as well as from HMW- and LMW-glutenins have been
described, various studies have indicated that the a-gliadins are
among the most immunogenic regarding CD [8–10,13,25]. A
crucial step towards the elimination of gluten toxicity would thus
be the elimination of T cell stimulatory a-gliadin sequences. Our
extensive genetic analysis of over 3000 a-gliadin transcripts from
different bread wheat accessions showed a high heterogeneity of
Figure 3. Response of DQ2-Glia-a1 epitope specific T cell clones against single and multiple P to S substituted peptides. Five T cell
clones derived from 3 CD patients were tested against the deamidated form of the DQ2-Glia-a1 peptide (sequence PFPQPELPY) and variants thereof
in which prolines at position 3, 5, 8 and 10 were systematically substituted for serine, both as single substitutions and in all possible combinations.
Shown is the response to the substituted peptides relative to unsubstituted DQ2-Glia-a1 epitope. The introduced substitutions are underlined. The
most C-terminal substituted proline at position 10 lies outside the 9 amino acid core of the T cell stimulatory peptide.
doi:10.1371/journal.pone.0015637.g003
Figure 2. Amino acid substitution eliminates toxicity of known a-gliadin epitopes. The DQ2-Glia-a3 epitope and the known 33-mer were
synthesized in deamidated form either as the original sequence or after substitution in each epitope of the prolines at position 8 with serine. These
peptides were tested in T cell proliferation assays. A: T cell proliferation assay using a DQ2-Glia-a3 T cell clone. B: T cell proliferation assay using a
DQ2-Glia-a1 T cell clone. Positive control: synthetic peptide encoding the specific minimal T cell epitope. Stim. index: stimulation index defined as the
specific proliferation of a sample divided by the background proliferation.
doi:10.1371/journal.pone.0015637.g002
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the a-gliadins genes and considerable differences in the number of
T cell stimulatory sequences encoded by the various a-gliadin
genes. We identified three major factors determining these
differences: i) the length of tandem repeats of antigenic sequences;
ii) natural amino acid substitutions that affect the antigenicity of T
cell epitopes, and iii) amino acid deletions that eliminate the
antigenicity of T cell epitopes.
The a-gliadins from locus Gli-D2 generally encode several
copies of both the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes in
addition to the DQ2-Glia-a3 and DQ8-Glia-a1 epitopes, Gli-A2
genes usually encode only the DQ2-Glia-a1 and DQ2-Glia-a3
epitopes while the Gli-B2 genes encode no or at most one DQ2-
Glia-a1 epitope, next to the DQ8-Glia-a1 epitopes. The 33-mer
sequence with 6 T cell stimulatory sequences [13] was only found
in a minority of the a-gliadins analyzed, all of which are expressed
from Gli-D2. Many natural occuring amino acid substitutions
affecting the antigenicity of the canonical a-gliadin peptides were
identified. Typical examples are the proline to serine substitution
at p8 in the DQ2-Glia-a2 epitope and the arginine to proline
substitution at p2 in the DQ2-Glia-a3 epitope, that both
completely eliminate the T cell stimulatory properties of these
peptides.
The analysis of gluten extracts from the diploid wheat varieties
underscores these observations and provides a molecular basis for
the previous observation that A-genome diploid T. monococcum
varieties lack the DQ2-Glia-a2 epitope [18]. All a-gliadins from
this genome encode an altered version of the DQ2-Glia-a2 epitope
with a serine at p8 that fails to induce T cell responses. We
observed that a similar substitution eliminates the T cell
stimulatory properties of the DQ2-Glia-a1 and DQ2-Glia-a3
epitopes. The more variable reaction pattern of T-cells and
antibodies towards gluten extracts of the S-genomes reflects the
higher level of genetic variation in these outcrossing species. These
a-gliadins contain another variant of the DQ2-Glia-a1 and DQ2-
Glia-a2 region that does not incude the A-genome specific serine
at p8. Furthermore, amino acid deletions in the canonical a-
gliadin peptides prohibit binding to HLA-DQ2 and hence T cell
recognition. A typical example is the deletion of the glutamine at
p4 in the DQ2-Glia-a1 epitope which generates a peptide that no
longer binds to HLA-DQ2, presumably due to defective docking
of the anchor residues into their respective pockets in the HLA-
DQ2 molecule. Our results confirm previous observations [18,19]
that the a-gliadin locus Gli-D2 encodes the most toxic a-gliadins
while substantially less toxicity is associated with those from Gli-A2
and Gli-B2, but also provide the molecular basis for these
differences.
Unfortunately, due to the complexity of both the Gli-2 gene
family and the wheat genome, it will be a difficult task to generate
tetraploid pasta and hexaploid bread wheat that is entirely safe for
consumption by all CD patients by conventional breeding
methods. Our results now provide a rationale for an alternative
approach as we demonstrate that by the introduction of naturally
occurring amino acid substitutions the toxicity of all four T cell
epitopes in a-gliadins can be eliminated. Using novel methods
such as zinc finger nucleases [26–28] we can introduce the
underlying SNPs as specific mutations into the a-gliadin genes of
wheat to eliminate toxicity completely. Technically this will not be
easy, but our results indicate precisely the three complementary
sets of actions that need to be performed.
i) In the Gli-B2-derived a-gliadins analyzed, none of the DQ2
epitopes are present due to a single amino acid deletion in the
region encoding the DQ2-Glia-a1 and DQ2-Glia-a2 epitopes,
which generates a peptide that has decreased binding affinity for
HLA-DQ2 and is no longer recognized by T cells. Therefore, a
single amino acid substitution in the DQ2-Glia-a3 epitope will
result in a peptide that has completely lost HLA-DQ2 binding
properties and T cell stimulatory properties. To eliminate the
remaining DQ8-Glia-a1 epitope in some Gli-B2 a-gliadins, a
single glutamine to arginine substitution, which naturally occurs in
the a-gliadins from the A-genome, would suffice. Such a minimally
genetically modified B-genome a-gliadin gene would thus no
longer encode any T cell stimulatory peptides. Moreover, by
starting with an a-gliadin gene in which the sequence of the p31-
43 peptide is naturally altered (for example the gene encoding
protein no. 9 in SI 2), the chance of innate immune stimulation by
a protein derived from such a gene would also be minimized.
ii) For Gli-A2 a-gliadins, the approach to eliminate toxicity
would be to introduce two proline to serine substitutions at p8 in
the DQ2-Glia-a1 and DQ2-Glia-a3 epitopes present. As these a-
gliadins genes encode a shorter version of the immunodominant
33-mer in which the DQ2-Glia-a-2 epitope is already non-
functional, and contain a version of the DQ8-Glia-a1 epitope that
has no T cell stimulatory properties, these two substitutions would
completely remove toxicity in proteins encoded by such modified
genes.
iii) Regarding the Gli-D2 a-gliadins, we found that the proline to
serine substitutions at p8 completely abrogated the in vitro T cell
stimulatory properties of the 33-mer peptide and of an elongated
version of the 33-mer that also encodes the DQ2-Glia-a3 epitope.
This result underscores our previous observation that most T cell
stimulatory gluten peptides have a proline at p8 [24]. However, to
render a-gliadins from the D-genome non-toxic, up to seven
substitutions need to be introduced in a single gene.
An alternative approach is to design safe a-gliadin genes that
can subsequently be introduced into celiac disease safe cereals such
as rice or maize, for the production of gluten proteins. As such
modified proteins will be very similar to existing a-gliadins they
will most likely have indistinguishable technological properties.
Thus, such gluten proteins could enhance the baking properties of
these cereal crops, or they could be extracted from these crops and
used as an ingredient to generate novel high quality foods for
celiac disease patients. For the generation of high quality cereals
that can replace wheat-based products the simple introduction of
detoxified a-gliadins is unlikely to be sufficient, as baking quality is
mostly determined by the HMW and LMW glutenin proteins.
Therefore, additional studies will have to investigate how other
gluten proteins can be detoxified as there is substantial evidence
that these contain T cell stimulatory peptides as well. In previous
studies we provided evidence that such epitopes can be found in
the c-gliadins as well as in the LMW- and HMW-glutenins [11,12]
and others have extended these observations [14,25]. In particular,
we found that T cell responses to LMW-glutenins were found in
children while these are much less frequent in adults [12,25].
Moreover, in a recent study a highly antigenic v-gliadin peptide
was described [25] that is identical to an antigenic hordein-derived
peptide reported by us earlier [20]. In essence this hordein/omega
peptide is a sequence variant of the DQ2-Glia-a1 peptide and also
carries a proline at the p8 position [20]. It is therefore feasible that
the toxicity of this peptide can be eliminated by a proline to serine
substitution at p8 as well. Preliminary results show that amino acid
substitutions similar to those that destroy the T cell stimulatory
properties in a-gliadins might also be effective for c-gliadin derived
epitopes (Salentijn et al, in prep), but it is likely that for the LMW-
and HMW-glutenins other approaches will be required. This will
be the subject of further studies.
In conclusion, we have demonstrated that by utilizing naturally
occurring amino acid substitutions the toxicity of the four T cell
epitopes in a-gliadins can be eliminated. Such modified proteins
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will most likely display indistinguishable technological properties.
Thus, our results provide a rational approach to eliminate CD
related toxicity from a-gliadins, which represents a first but crucial
step towards the realization of safe gluten containing food products
for CD patients.
Materials and Methods
Analysis of a-gliadin transcripts from diploid wheat
varieties
T. monococcum accessions CGN10500, CGN12035 and
CGN10555 (CGN, Wageningen, The Netherlands) were used
for cloning and sequencing of a-gliadin transcripts. Plants were
grown under greenhouse conditions. Developing green kernels of
single plants were harvested and used for RNA isolation according
to Doyle and Doyle [29] but with 1% (w/v) poly-(vinylpyrroli-
done)-10 in the extraction buffer. For the production of first strand
cDNA 1 mg of total RNA was treated with DNAse I (Invitrogen,
amplification grade; 18068-015) followed by RT PCR (Invitrogen
SuperScript III First-Strand Synthesis System for RT-PCR;
18080-051) using random hexamer primers in a final reaction
volume of 20 ml. Primers specific for a-gliadin genes, located on
the conserved sequences at the 59 and 39 end of the coding region
of the a-gliadin, were used to amplify a-gliadin transcripts from
the cDNA samples (aF1: 59-atgaaRaCmtttcYcatc and a5R: 59-
gttagtaccgaNgatgcc). The PCR conditions: 5 min. at 94uC, 30
cycles (94uC for 1 min., 49uC for 1 min. and 72uC for 2 min),
72uC for 10 min, 25 ml reaction volume. The PCR products were
cloned and sequenced.
Characterization of expressed a-gliadin sequences
Over 3200 T. aestivum expressed sequence tags (ESTs) and
mRNAs designated as a-gliadin or a/b-gliadin were downloaded
from the NCBI UniGene library (Ta.15268, Ta.23792, Ta.24084,
Ta.25210, Ta.27702, Ta.28482) (http://www.ncbi.nml.nih.gov/
UniGene) on 13 April 2007. The sequences were from T. aestivum
libraries of various tissues, treatments and cultivars (Chinese
Spring 34.2%; Glenlea 20.8%; Cheyenne 10.4%; Recital 7.8%;
Mercia 7.2%; unknown cultivar 8.9%; Wyuna 3.2%; HiLine
2.9%; Butte 86, 2.4%; Hartog 1.5%; Soleil 0.6%; Nostar 0.1%;
Novobirskaya 67, 0.1%). The DNA sequences were aligned using
the SeqMan II (DNAstar) and first assembled at a minimum
match percentage of 60%, gap lengths 3200, maximum match size
50 bp. BLAST analysis of the contigs was performed to verify the
a-gliadin identity of the contigs and short (,100 bp) and bad
sequences were discarded. The transcript contigs of $60%
homologous sequences were trimmed up to the start and stop
codons. Next, the sequences were reassembled at 90% homology,
which resulted in 55 a-gliadin transcript contigs containing 1 to
475 sequences. The 39 end was covered by 50 contigs (2911
transcripts) whereas the 59 end was present in 30 contigs (2753
transcripts). The consensus of these contigs were saved in separate
files and used for phylogenetic studies to deduce the genome of
origin of the sequences in each contig.
Phylogenic analysis
With the aim to deduce the locus, Gli-A2, Gli-B2 or Gli-D2, from
which the transcripts were expressed, the 55 a-gliadin EST consensus
nucleotide sequences obtained from clustering, were aligned using
Clustal W,MEGA 4 [30], together with 56 genomic DNA sequences
of known origin, i.e. derived from the diploid wheat species T.
monococcum (A genome), T. speltoides (S genome) and Aegilops tauschii (D
genome) [18] and DNA sequences that were previously assigned to a
locus [31]. The sequences that covered the 59 region of the a-gliadin
sequences were trimmed up to the start and up to nucleotides coding
for the conserved amino acid motif PIS, located just in front of the
first glutamine repeat, to cover the same region and subsequently
used to generate a Neighbor-Joining tree (bootstrap test of 1000
replicates, pairwise deletion of gaps and missing data, Kimura 2-
parameter, Substitutions to Include Transitions + Transversions;
Pattern among Lineages Homogeneous, Uniform rates among sites,
number of sites = 750, in MEGA 4)(Fig. S1).
Sequence variation in epitope regions
To analyze all sequence variation, the 55 a-gliadin EST contigs,
now assigned to a specific chromosome, were reassembled one by
one at 99–100% match (SeqMan II, Lasergene, DNAstar). This
yielded 717 different allelic variants. The consensus nucleotide
sequences were translated (MEGA 4) and explored for epitopes
and surrounding sequence regions using a text explorer program
(PatternResearch, in house developed) after which the output file
was analysed in Excel.
T cell clones, T cell proliferation and HLA-DQ2 binding
assays
Gluten specific T cell clones were generated from small
intestinal biopsies of celiac disease patients as described before
[8,11,12]. All patients signed an informed consent form which was
approved by the hospital ethics committee. Proliferation assays
were performed in triplicate in 150 ml Iscove’s Modified
Dulbecco’s Medium (Bio Whittaker, Verviers, Belgium) with
10% pooled normal human serum in 96 well flat-bottom plates
using 26104 gluten specific T cells stimulated with 105 irradiated
HLA-DQ2-matched allogeneic peripheral blood mononuclear
cells (3000 rad) in the presence or absence of antigen (1–10 mg/ml)
[8,11,12]. After 2 days 3H-thymidine (0.5 mCi/well) was added to
the cultures, and 18–20 hours thereafter the cells were harvested.
3H-thymidine incorporation in the T cell DNA was determined
with a liquid scintillation counter (1205 Betaplate Liquid
Scintillation Counter, LKB Instruments, Gaithersburg, MD). A
binding assay was performed as described previously [24].
Supporting Information
Figure S1 Phylogenetic analysis of a-gliadin sequences.
A neighbor-joining tree was made with 55 EST consensus
nucleotide sequences from hexaploid bread wheat together with
56 genomic DNA sequences derived from the diploid wheat
species T. monococcum (A genome, green dots), T. speltoides (S/B
genome, blue dots) and Aegilops tauschii (D genome, red dots), after
alignment using Clustal W. The EST sequences (black dots) can be
assigned to their locus in hexaploid bread wheat as they cluster
into the same three groups as the sequences from the diploid
species (A genome = locus Gli-A2, S/B genome = locus Gli-B2, D
genome = locus Gli-D2 [17]).
(TIF)
Figure S2 Sequence variation in the N-terminal and C-
terminal regions of a-gliadin genes from hexaploid
wheat. The 23 most frequently found expressed sequence tag
(EST) contigs were translated, the amino acid sequences were
aligned and grouped per chromosomal location (the Gli-A2 locus
on chromosome 6AS, Gli-B2 on 6BS, and Gli-D2 on 6DS) to
present the variation in various gluten epitope regions. Note the
large differences in the number of times (N) each sequence was
present in the set of ESTs. In red: amino acid variation in the
sequence. In back: chymotrypsin or trypsin sites (.72% affinity).
(TIF)
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Figure S3 DQ2-Glia-a1 variants. The effect of various
amino acid substitutions on the ability of the DQ2-Glia-a1
peptide to stimulate DQ2-Glia-a1 T cells.
(TIF)
Table S1 Amino acid sequences of the DQ2-Glia-a1/-
a2/-a3 region of a-gliadin cDNA transcripts from three
diploid T.monococcum accessions (diploid, AA genome).
The gene sequences have been submitted as accession numbers
HQ317881-HQ317890.
(DOC)
Table S2 The effects of proline to serine substitutions
in an elongated version of the 33-mer, which also
encodes the DQ2-Glia-a3 epitope.
(DOC)
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